|
original article |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
2024―Mar―26 |
A Retrospective Study on Azvudine in Hospitalized Elderly Patients with
COVID-19 |
Ruifang Nie, Ning Hou, Ke Xu, Shan Shen, Shuangshuang Yang |
2 |
[GO] |
2024―Mar―26 |
Analysis of Suicide-related Tweets During the COVID-19 Pandemic |
K.D.S. Balasooriya, R.A.H.M. Rupasingha, B.T.G.S. Kumara |
3 |
[GO] |
2024―Mar―26 |
Spectroscopic Analysis of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-COV-2) |
Prashant Hitaishi, Akash Anandrao Parab, Rohit Verma, Parul Khurana, Sheenam Thatai |
4 |
[GO] |
2024―Mar―26 |
Long COVID: A Case Report of Long SARS-CoV-2 for One Year |
Negar Mottaghi-Dastjerdi, Mehdi Yadollahzadeh, Maryam Farasatinasab, Hamid Owliaey, Marjan Shariatpanahi |
5 |
[GO] |
2024―Mar―25 |
Association Between Changes in Haematological Parameters and Mortality in Patients Hospitalized Due to Severe COVID-19 in a Peruvian Reference Hospital |
Claudia Benavides-Luyo, Annie Velasquez-Manrique, Dante M Quiñones-Laveriano, Susan Chaupi-Rojas, Johan Azañero-Haro, Alonso Soto |
6 |
[GO] |
2024―Mar―18 |
Which Laboratory and Clinical Feature are different in Pregnant and Non-pregnant Women with COVID-19? A Cross-sectional Study in the West of Iran |
Elaheh Talebi-Ghane, Nahid Radnia, Fariba Daneshvar, Maryam Garousian, Saeed Bashirian, Salman Khazaei, Neda Alimohammadi |
7 |
[GO] |
2024―Mar―05 |
A Comprehensive Report on Long COVID, Emerging Challenges, and
Research Priorities in the Pandemic |
Mohd Mustafa, Kashif Abbas, Safia Habib |
8 |
[GO] |
2024―Mar―01 |
Comparison of Changes in Liver Function Tests in Pregnant Women with Mild and Severe COVID-19 |
Parichehr Pooransari, Razieh Pouransari, Mahboobeh Gharib Laki, Zhila Abedi Asl, Samira Yavari, Reza Hosseiniara |
9 |
[GO] |
2024―Mar―01 |
The Level of Knowledge and Performance of Iranian Medical Students in The Second Year of the COVID-19 Pandemic |
Mohammad Shahin Shahvardizadeh, Faranak Rezaei, Shahnaz Halimi, Somayeh Delfani, Pegah Shakib, Setareh Soroush |
10 |
[GO] |
2024―Feb―14 |
Biochemical and Familial Factors Influencing COVID-19 Disease
Progression |
Rıza Altunbaş, Aziz Batu, Adnan Türkel, Ali Akin, Umut Tendik |
11 |
[GO] |
2024―Feb―13 |
A Comparison Between the Photodynamic Action of “Hypocrellin A” and
“Pheophorbide A” Against Bacteria and SARS-CoV-2 Virus --- A MiniReview |
Siu Kan Law |
12 |
[GO] |
2024―Feb―01 |
Investigating the Relationship between COVID-19 In-hospital Death and
Acute Kidney Injury |
Ramin Haghighi, Nikoo Fereyduny, Mohammad Bagher Oghazian, Ashkan Haghighi, Amir Bigdeli, Amirhossein Sahebkar |
13 |
[GO] |
2024―Feb―01 |
Impact of MDRs on COVID-19 Patients Among Developing Countries |
Alok Bharadwaj |
14 |
[GO] |
2024―Jan―29 |
In silico Evaluation of Anacyclus pyrethrum Composition for Inhibition of Spike RBD-ACE-2 Interaction to Treat COVID-19 |
Anand Kumar Pandey, Jayanti Awasthi, Kislay Chaturvedi, Ayush Mishra, Shivangi Yadav, Soumya Rathore, Preeti Birwal |
15 |
[GO] |
2024―Jan―29 |
COVID-19 Vaccines: A Comprehensive Review of Development, Action
Mechanisms, and Global Implications |
Sandhya Rajbahadur Yadav, Pushpalata Chougule |
16 |
[GO] |
2024―Jan―26 |
Antiviral Medications: Unravelling their Significance in Context to COVID-19 |
Rishabh Chalotra, Amanjot Singh, Shivani Chib, Swati Gautam, Muhammed Amanat, Kakul Chaudhary, Manish Kumar, Randhir Singh |
17 |
[GO] |
2024―Jan―26 |
Use of COVID-19 Personal Protective Equipment (PPE) Among
Healthcare Workers in Teaching Hospitals of Khorramabad, Iran |
Mehdi Zibaei, Shahnaz Halimi, Faranak Rezaei, Setareh Soroush, Pegah Shakib |
18 |
[GO] |
2024―Jan―26 |
In silico Designing of a Multi-epitope-based Subunit Vaccine against SARS-CoV-2 (Delta Variant) by Exploiting Its Structural Proteins: A Reverse Vaccinomics and Immunoinformatics Approach |
Sajal Kumar Halder, Ashish Ranjan Sharma, Tawsif Al Arian, Samantha Saha, Aparna Shil, Md. Oliullah Rafi, Satya Ranjan Sarker, Md. Nuhu Alam, Mahbubul Kabir Himel, Md. Ashraful Hasan, Mohammad Mahfuz Ali Khan Shawan |
19 |
[GO] |
2024―Jan―26 |
Immune-endocrine Interactions and Remodelling of Metabolic Homeostasis
of Testicular Cells During SARS-CoV-2 Infection |
Suvendu Ghosh, Debosree Ghosh, Partha Singha |
20 |
[GO] |
2023―Dec―27 |
Immunization against COVID-19: A Comprehensive Review on the
Leading Vaccines |
Ananyaa Srinivasan, Vijaishree Rajesh, Dharani Thamilvanan, Sanjeev K Ganesh, Subathra Devi. C |
21 |
[GO] |
2023―Dec―20 |
Natural Products as Inhibitors of Coronavirus: An Update |
Ritu Kalia, Sanjay Jachak, Akash Dey |
22 |
[GO] |
2023―Dec―19 |
Comparison of Women's Sexual Activity Before and After being Infected
with COVID-19 |
Zohreh Keshavarz, Naimeh Shariatifar, Malihe Nasiri, Zahra Kiani |
23 |
[GO] |
2023―Dec―19 |
Analyzing Uttarakhand's COVID-19 Outbreak: Demographic Insights and
Strategies for Future Pandemic Prevention |
Gaurav Joshi, Akshara Pande, Omdeep Gupta, Anoop Nautiyal, Sanjay Jasola, Prashant Gahtori |
24 |
[GO] |
2023―Dec―19 |
Methodical and Immunological Insights of Prime COVID-19 Vaccines |
Wilson Pearl Evangeline, Sakthivel Nathan Divyasri, Chandrasekaran Akshaya, Sekaran Sruthi, Selvaraj Barathi, Rangasamy Kirubakaran, KN ArulJothi |
25 |
[GO] |
2023―Dec―12 |
The Interweaving of Pain and Perfection: A Qualitative Inquiry about the
Experiences of Pregnant Women during Pregnancy and Childbirth in the
COVID-19 Pandemic in Iran |
Akram Parandeh, Batool Nehrir, Mohammad Mehdi Salaree, Mona Larki, Somayeh Makvandi, Leila Karimi |
26 |
[GO] |
2023―Dec―12 |
In silico Molecular Docking of SARS-CoV-2 Surface Proteins with
Benzimidazole Scaffolds: Strategy to Discover Lead Compounds |
Monika Meghani, Shikha Sharma, Nitin Kumar, Biswa Mohan Sahoo |
27 |
[GO] |
2023―Dec―08 |
Relationship between COVID-19 and Neurological Disorder |
Shivendra Mani Tripathi, Pratik Kumar Vishwakarma, Smriti Ojha, Sudhanshu Mishra |
28 |
[GO] |
2023―Dec―07 |
Recent Scenario of the Indian Healthcare System Post COVID-19 Emergence and in Severely Ill Patients |
Sushant Mishra, Shushank Mahajan, Able Mogha, Abhinav Yadav, Wandeep Dagar, Isha Chawla, Meenakshi Dhanawat |
29 |
[GO] |
2023―Dec―07 |
Exploring Effective Therapeutic Approaches for COVID-19: A Review on
Progress and Prospects |
Oritoke M. Okeowo, Nzube F. Olung, Omamuyovwi M. Ijomone, Ayotunde S. Adeagbo |
30 |
[GO] |
2023―Dec―07 |
Maternal and Neonatal Outcomes after Vaccination with SARS-CoV-2: A
Systematic Review and Meta-analysis of Cohort Studies |
Anand Vijayakumar Palur Ramakrishnan, Roopa Satyanarayan Basutkar, Sugash Murugan, Shonitha Sagadevan, Oorvashree Sri Hari, Shanmuga Priyan |
31 |
[GO] |
2023―Dec―01 |
COVID-19 Vaccine Practices and Perceptions Among an Academic
Healthcare Community |
Samiksha Prasad, Waseem Wahood, Darisel Ventura Rodriguez, Amanda J. Chase |
32 |
[GO] |
2023―Nov―15 |
Utilization of Telehealth in Kenya During COVID-19 |
Calvin R. Wei, Godwin C. Lang'at |
33 |
[GO] |
2023―Nov―15 |
COVID-19 Pandemic and its Economic Impact on the Global Economy: A Computable General Equilibrium Approach |
Esambe Sone, Jong-Hwan Ko |
34 |
[GO] |
2023―Nov―15 |
Colchicine with Infliximab Compared to Infliximab in Hospitalized Patients with COVID-19 Pneumonia: An Open-label Randomized Trial |
Mahdi Yadollahzadeh, Somayyeh Nasiripour, Najmeh Moradi Shahrbabak, Nader Rezaie, Mohsen Farrokhpour, Mehdi Azimi, Shirin Izadi, Farhad Zamani, Maryam Farasatinasab, Hootan Diba |
35 |
[GO] |
2023―Nov―15 |
Exploring the Efficacy of Traditional Herbs in Combating COVID-19: A Comprehensive Review |
Anil Sao, Tulsidas Nimbekar, Garla Venkateswarlu, Mohit Mishra, Aditya Kate, Meenakshi Kanwar Chauhan, Chandrashekhar Mahadeo Chakole |
36 |
[GO] |
2023―Nov―15 |
Off-label Use of Medicines in COVID-19: A Lesson For Future |
Aliasghar Hemmati, Hoda Mojiri-Forushani |
37 |
[GO] |
2023―Nov―15 |
Why Poor Countries were the Least Affected by COVID-19? |
Haitham Ahmed Al-Madhagi |
38 |
[GO] |
2023―Nov―15 |
New SARS-CoV-2 Mpro Inhibitor by Ascorbic Acid: Design, Molecular docking, Lipinski’s Rule and ADMET Analysis |
Mohammad Rashid, Md Tanwir Athar, Abdulrahman Salman Alazmi, Deepak Kumar, Raj Kumar, Keun Woo Lee, Aisha Alnami |
39 |
[GO] |
2023―Nov―07 |
Enterococcal Infections: A Comparative Analysis between the Pandemic
and the Pre-pandemic Period |
Neha Sharad, Smriti Srivastava, Vandana V Kiro, Sharin Varma, Sharad Srivastav, Aparna Ningombam, Rajesh Malhotra, Purva Mathur |
40 |
[GO] |
2023―Nov―06 |
Pandemic Preparedness for COVID-19: Research, Healthcare, and Pharmaceutical Perspectives |
Israel Mani, Manikandan B.N, Amarabalan B, Mohamudha Parveen R, Mohan Pandi |
41 |
[GO] |
2023―Nov―06 |
Polyherbal Syrup for Coronavirus Infection: Formulation and Evaluation |
K. Kranthi Kumar, Sunil Kumar Kadiri, Sampath. A. G |
42 |
[GO] |
2023―Nov―02 |
Biomarkers can Predict COVID-19 Disease |
Utkarsh Sharma, Shikha Sharma |
43 |
[GO] |
2023―Nov―01 |
Traditional Therapies Involving Nutrition for the Management of COVID-19 |
Ramesh M, Arunachalam Muthuraman, Krishnan Anand |
44 |
[GO] |
2023―Nov―01 |
Amidst Cytokine Storm in Metabolic Diseases: Can 2-deoxy-D-glucose (2-
DG) Cure COVID-19? |
Shweta Shrivastava, Ayush Kumar, Manish Kumar Jeengar, Elsy Xavier, Prashant Tiwari |
45 |
[GO] |
2023―Oct―26 |
COVID-19: Different Strains of Corona, Vaccine Efficacy, Treatment, Medical Ethics, and Future Perspectives |
Sonia Singh, Ashima Ahuja, Raghavan Ramankutty, sarada Ramaswamy |
46 |
[GO] |
2023―Oct―25 |
Molecular Docking Analysis of SARS-CoV-2 Inhibitor N3 (6LU7) against
Selected Flavonoids and Vitamins |
Sunil Junapudi, Yasodha Krishna Janapati, Susmitha Uppugalla, Timothy Harris, Muhammad Yaseen, Muhammad Latif |
47 |
[GO] |
2023―Oct―24 |
Phytochemical Profiling of Borassus flabellifer Haustorium and its Potential Role in Combating COVID-19-Associated Encephalopathy: A Computational Perspective |
Noorul Samsoon Maharifa Haja Mohaideen, Hemalatha Srinivasan |
48 |
[GO] |
2023―Oct―17 |
Computational Investigation of Endophytic Fungal (Penicillium citrinum
CGJ-C2) Compound and its In-silico Derivatives on the Inhibition of
RNA-dependent RNA Polymerase of SARS-CoV2 |
Jagadeesha Poyya, Ananda Danagoudar, Chandrasekhar G Joshi, Ajay S Khandagale, Raju N. G |
49 |
[GO] |
2023―Oct―15 |
Efficiency of CAT and L-SIGN as Alternative or Co-receptors for SARS-CoV-2 Spike Protein |
CHAINEE DAS, VENKATA SATISH KUMAR MATTAPARTHI |
50 |
[GO] |
2023―Oct―11 |
Ultrastructural Blood Cell Changes in Patients with COVID-19 |
Yulian Kyyak, Olga Barnett, Olha Labinska, Orysia Kysil, Marta Halkevych |
51 |
[GO] |
2023―Oct―11 |
Mental Health and Stigmatization Linked to the COVID-19 Pandemic |
Sunil Kumar Kadiri, Shakshi Mundhra, Prashant Tiwari |
52 |
[GO] |
2023―Sep―18 |
Barriers and Motivating Factors in Receiving COVID-19 Vaccination among the Healthcare Workers of Tehran Military Hospitals |
Mahmoudreza Hashemi Rafsanjani, Majid Nouri, Ali Omrani Nava, Mohammad Darvishi |
53 |
[GO] |
2023―Sep―14 |
Mechanistic Insights on Viral Factors Involved in Asymptomatic COVID-19 Pathogenesis |
Satinder Kaur, Renu Bala, Prakash Chandra Mishra, Vineeta Singh, Rachna Hora |
54 |
[GO] |
2023―Sep―11 |
A Registry-based Audit of a Current Situation of Clinical Research in COVID-19 Using Artificial Intelligence Techniques: A Systematic Review |
Pugazhenthan Thangaraju, sree sudha ty, Hemasri Velmurugan, Eswaran Thangaraju, Kaumudi Chirumamilla, Tulika Chakrabarti, Prasun Chakrabarti |
55 |
[GO] |
2023―Sep―06 |
Investigation of Reported Anaphylaxis Post COVID-19 Vaccination in Subjects with History of Allergies and Anaphylaxis |
Aditya P. Desai, Aryan P. Desai, Victoria S. Ochs, Prashant V. Desai |
56 |
[GO] |
2023―Aug―25 |
In Silico Study of Alkaloid Compounds with Computational Approach for Selection of Drug Leads for COVID-19 |
Arli Aditya Parikesit, Stephanie Audrey Victoria, Ihsan Tria Pramanda |
57 |
[GO] |
2023―Aug―23 |
Multidrug-resistant Tuberculosis and its Implication with COVID-19 |
Anil Kumar Chhillar, Jasmine Arya, Sweety Dahiya |
58 |
[GO] |
2023―Aug―23 |
Ethical Challenges at the Time of the Covid-19 Pandemic - A Systematic Review |
Pugazhenthan Thangaraju, Hemasri Velmurugan |
59 |
[GO] |
2023―Aug―23 |
Analysis of Research Publication on Logistics at the Time of COVID-19: A Scientometric Study |
Pugazhenthan Thangaraju, Ku Krishna Verma, Hemasri Velmurugan, Himanshu Nirmal Chanu, Tulika Chakrabarti, Prasun Chakrabarti, Sajitha Venkatesan |
60 |
[GO] |
2023―Aug―10 |
My Quarantine Diary: a tool for self-care and learning about COVID-19 |
Alan Maicon de Oliveira, Luana Michelly Aparecida da Costa, Guilherme José Aguilar, Luiz Ricardo Albano dos Santos, Wilbert Dener Lemos Costa, Dantony de Castro Barros Donato, Felipe Foresto, Valdes Roberto Bollela |
61 |
[GO] |
2023―Aug―04 |
Criticism of the HAS Opinion of July 21st, 2022, on Maintaining of the SARS-Cov-2 Vaccine Mandate for Healthcare Workers |
Jérôme Sainton |
62 |
[GO] |
2023―Aug―01 |
Mucormycosis: A serious catastrophe involving COVID-19 patients |
Neha Dangi, Himanshu Mehendiratta, shikha sharma |
63 |
[GO] |
2023―Jul―27 |
Impact of Prolonged use of COVID-19 Drugs on the Human Neurological System using Insilco Drug-gene Interaction |
Prachi Srivastava, Wayez Naqvi, Prekshi Garg |
64 |
[GO] |
2023―Jul―26 |
Assessment Of Traces Of Sars-Cov-2 Rna In A Laboratory Setting Using In Vitro-Diagnostic Rt-Qpcr |
Arbind Kumar, Sanjay Kumar, Suresh Kumar, Lal Chand Pal, Sahdev Choudhary |
65 |
[GO] |
2023―Jul―10 |
Explaining why Africa had much lower COVID-19 fatalities per million than Europe and North America |
Alberto Boretti |
66 |
[GO] |
2023―Jun―26 |
A Case Report on Covid-19 Causing New Onset of Diabetes Even with No History |
Amit Sharma, Manisha Vohra, Mohammad Amir, Ian Osoro |
67 |
[GO] |
2023―Jun―09 |
A systematic review of covid-19 impact on cardiovascular diseases |
Mohd Zafar Khan, Mohammad Khushtar, Juber Akhtar, Mohammad Irfan Khan, Mohammad Ahmad, Ishana Chand |
68 |
[GO] |
2023―May―09 |
Finding the potential inhibitory activity of Vilanterol Versus Budesonide towards SARS-CoV-2 Mpro: A molecular dynamics simulation approach |
Afzal Hussain, Ashfaq Hussain |
69 |
[GO] |
2023―Apr―18 |
Coronavirus Disease (COVID-19): Features, Diagnosis, Treatments, and Impacts |
Ayush Dogra, Bhawna Goyal |
70 |
[GO] |
2023―Apr―11 |
COVID-19: Mortality rate (in time)
An Analysis of Publicly Available Data from 11 Countries to Calculate the Mortality Rate of COVID-19 |
Rien Bosma |
71 |
[GO] |
2023―Apr―04 |
Herbal Medicines Used for the Management of COVID-19 |
Virender Kumar, Yogesh Kumar, Rajat Huria, Suryadev Kumar, Tarun Kalson, Deepak Jangra, Davinder Kumar, Bharti Mangla |
72 |
[GO] |
2023―Mar―30 |
Moisturizer and COVID-19: Are We Missing a Trick? |
Srinivasan Tantravahi, Chenna R Galiveti |
73 |
[GO] |
2023―Mar―30 |
Exploring the Possibility of use of SARS-CoV-2 Antiserum as an Alternative for Plasma Therapy |
Basavraj Nagoba, Ajay Gavkare, Abhijit Rayate |
74 |
[GO] |
2023―Mar―30 |
Different Variants of SARS-COV-2: A Comprehensive Review on Mutation Patterns and Pathogenicity |
Mohammad Faheem Khan, Fahmina Rizvi, Mohsin Ali Khan, Waseem Ahmad Ansari, Kajim Ali, Mohd. Aamish Khan |
75 |
[GO] |
2023―Feb―28 |
The Use of Antivirals Against COVID-19 Infection will Reduce the Number of Fatalities in Australia |
Alberto Boretti |
76 |
[GO] |
2023―Jan―03 |
A recent update on SARS-CoV-2 transmission and its variants: Transmission, pathogenic mechanism, and treatment |
Vishal Mishra, Veer Singh, Shreyans K Jain |
77 |
[GO] |
2022―Dec―12 |
Emergence of BA.4/BA.5 Omicron Sub-lineages and Increased SARS-CoV-2 Incidence in Senegal |
Moussa Moise Diagne, Amadou Diallo, Safietou Sankhe, Ndeye Marieme Top, Mouhamed Kane, Maimouna Mbanne, Martin Faye, Mamadou Aliou Barry, Ndongo Dia, Amadou Alpha Sall, Cheikh Loucoubar, Ousmane Faye |
78 |
[GO] |
2022―Dec―07 |
COVID-19 mortality and the cytokine storm: An added value for APOE genotyping |
Luis Diambra, Reza Rastmanesh |
79 |
[GO] |
2022―Dec―06 |
An In-Silico Multi-Targeted Approach in Search of Potential Drug Candidate(s) Against SARS-CoV-2 Lung Infection |
Joohee Pradhan, Kapish Kapoor, Vishnu Das, Ayushi Bhatnagar, Sunita Panchawat |
80 |
[GO] |
2022―Nov―24 |
Landscape Analysis of Quercetin: A Potential Candidate Against SARS-CoV-2 |
Kamal Niaz, Furqan Shafqat, Shafeeq Ur Rehman, Omazia Nasir, Ayesha Sarwar |
81 |
[GO] |
2022―Aug―30 |
Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta Indica (Indian Neem) against Delta and Omicron Variants of SARS-CoV-2 |
Mohammad Faheem Khan, Waseem Ahmad Ansari, Fahmina Rizvi, Mohsin Ali Khan, Zaw Ali Khan |
82 |
[GO] |
2022―Aug―19 |
Examining the Causes of Maternal Mortality in Pregnant Women since the Beginning of the COVID-19 Pandemic in Hamadan Province, Western Iran: A Research Article |
Samereh Ghelichkhani, fariba keramat, Ebrahim Jalili, faezeh moshayedi, Seyedeh Zahra Masoumi, azam midwifery, mostafa Eghbalian, venus hajialiakbari, fatemeh shahbazi |
83 |
[GO] |
2022―Aug―04 |
The COVID-19 Crisis: Impact on the Education System and How to Change the Way of Learning |
Bentham Science Publisher Bentham Science Publisher |
84 |
[GO] |
2022―Jul―06 |
COVID-19 and Tuberculosis: Two Knives in a Sheath |
Meenakshi Sundaram Kishore Kumar, Attuluri Vamsi Kumar, Thomas Alphonsa, Sangeetha Rajendran, Krishnamurthy Rajamanickam, Alemtoshi A, Vellingiri Balachandar, Bharali Pranjal, Bupesh Giridharan, Konda Mani Saravanan |
85 |
[GO] |
2022―Jun―24 |
Overview of SARS-CoV-2 and possible targets for the management of COVID-19 infections |
Arunachalam Muthuraman, Muthusamy Ramesh, Aswinprakash Subramanian, Jagadeesh Dhamodharan, Lim Khian Giap |
86 |
[GO] |
2022―Jun―08 |
The COVID-19 Pandemic: To Improve Public Acceptance, Don’t Keep Them in the Dark, Educate Them |
Joseph M. Rosen, Jill R. Sensenig |
87 |
[GO] |
2022―Jun―03 |
In Silico Modeling of COVID-19 Pandemic Course Differentiation Using the FOD Model |
Irena Roterman, Katarzyna Stapor, Piotr Fabian, Leszek Konieczny |
88 |
[GO] |
2022―May―27 |
Engineered Soluble ACE2 Protein and SARS-CoV-2 Variants of Concern (VOCs) |
Wattana Leowattana |
89 |
[GO] |
2022―Apr―11 |
COVID-19 Stress on Mental and Hair Health: A Marker for Diseases in the Post-Pandemic Era? |
Daniela Xavier Accorsi, Ingrid Aparecida Mendes dos Santos, Juliana Xavier Accorsi, Ursulandréa Sanches Abelan, Celso Martin Júnior, Silvia Bohac, Valéria Bumiller-Bini, Angelica Beate Winter Boldt, Chung Man Chin |
90 |
[GO] |
2022―Mar―29 |
Traditional therapies involving nutrition for the management of COVID-19 |
Ramesh M, Arunachalam Muthuraman, Krishnan Anand |
91 |
[GO] |
2022―Mar―25 |
Functional role of natural antioxidants for controlling oxidative stress associated with SARS-Cov-2 infection |
Subramani Parasuraman, Venkata Kanthi Vaishnavi Vedam, Chakradhara Rao S Uppugunduri |
92 |
[GO] |
2022―Mar―03 |
Recent advances in understanding SARS-CoV-2 infection and updates on potential diagnostic and therapeutics for COVID-19 |
Damini Verma, Amit K. Yadav, Navneet Chaudhary, Maumita Das Mukherjee, Pramod Kumar, Anil Kumar, Pratima R Solanki |
93 |
[GO] |
2022―Feb―06 |
The Concept Of Repurposing In Covid-19 Infection |
Lata Potey, Anshu Chaudhary Dudhe, Dhanashri Tumme, Rupesh Dudhea, Prafulla Sable |
94 |
[GO] |
2022―Jan―24 |
Green tea catechins against COVID-19? Lower COVID-19 morbidity and mortality in countries with higher per capita green tea consumption. |
Maksim Storozhuk |
95 |
[GO] |
2022―Jan―19 |
Assessment of Stress, Anxiety and Depression Level Among COVID-19 Positive Patients Admitted in Rural Tertiary Care Hospital |
Ramakant Yadav, Neha Dubey, Shweta Jain, Ankur Vaidya, Raj Kumar |
96 |
[GO] |
2022―Jan―18 |
Onco-immunological Aspect of COVID-19: Current Progress and Perceptions |
Suman Kumar Ray, Sukhes Mukherjee |
97 |
[GO] |
2022―Jan―18 |
LONG TERM NEUROLOGICAL EFFECTS AFTER ACUTE SARS-CoV-2 INFECTION |
Mohammad Asif |
98 |
[GO] |
2022―Jan―07 |
Is there a rendezvous for SARS-CoV-2 and Agmatine? |
Nandkishor Kotagale, Brijesh Taksande, Nazma Inamdar |
99 |
[GO] |
2021―Nov―23 |
Impact on Pharmaceutical Industry due to Sudden Pandemic Attack (COVID-19) |
Sudhanshu Mishra, Disha Sharma, Shobhit Prakash Srivastava, Swati Verma, Rishabha Malviya |
100 |
[GO] |
2021―Oct―23 |
Liver and Covid-19 - a review and clinical approach |
David L Fisher, Stephen Malnick |
101 |
[GO] |
2021―Sep―16 |
Alternative Management Of Cushing's Syndrome During Covid-19 Pandemic |
Serghei Covantev, Stanislav I. Volkov, Kristina I. Samsonova |
102 |
[GO] |
2021―Sep―16 |
Cytokine Storm and Immunomodulation in COVID-19: a Review |
Amir Mohammad Arsh, Suhana Mishra, Vishwas Tripathi, Amaresh Mishra |
103 |
[GO] |
2021―Sep―13 |
Cordycepin and its nucleoside analogs for the treatment of systemic COVID-19 infection |
|
104 |
[GO] |
2021―Sep―09 |
Total Stromal Fraction (TSF) - Fortified Adipose tissue-derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise |
Madhan Jeyaraman, Sathish Muthu, Rashmi Jain, Ajay SS, Neha Garg, Prabhu Mishra, Kumari Swati, Anand Parkash, Niraj Kumar Jha, Shreesh Ojha, Shubhadeep Roychoudhury, Dhruv Kumar, Janne Ruokolainen, Mohammad Amjad Kamal, Kavindra Kumar Kesari, Saurabh Kumar Jha |
105 |
[GO] |
2021―Aug―23 |
Withdrawal Notice: Therapeutically Important Natural Products and their Derivatives as a Target for Treatment of COVID-19 (SARSCoV2) |
Ashu Chaudhary |
106 |
[GO] |
2021―Aug―06 |
History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) |
Amaresh Mishra, Nisha Nair, Vishwas Tripathi, Yamini Pathak, Jaseela Majeed |
107 |
[GO] |
2021―Jul―29 |
COVID-19 Vaccines: Fabrication Techniques and Current Status |
Ayushi Mahajan, Lakhvir Kaur, Gurjeet Singh, RK Dhawan, Lovepreet Singh, Anureet Kaur |
108 |
[GO] |
2021―Jul―12 |
Identification of flavonoids as potent inhibitors against MERS-CoV 3C-like protease |
Fatemeh Abdi, Shahrzad Javanshir |
109 |
[GO] |
2021―Jul―12 |
SARS-CoV-2: Evaluation and Evolution |
Loay Bedda, Fayrouz Mahmoud, Radwa Elkhateib, Alyaa Dawoud, Hassan Gamal, Abdallah S. Abdelsattar, Ayman El-Shibiny |
110 |
[GO] |
2021―Jun―02 |
Immunosuppressant Drugs And Covid-19: Associated Risks, Drug-Drug Interactions & Contraindications |
Debjyoti Talukdar, Diane Ignacio, Madan Mohan Gupta |
111 |
[GO] |
2021―Mar―30 |
Lipid lowering natural products targeting hPCSK9 may prevent the severity of COVID-19 infection |
Ajoy Basak, Jaishree Vaijanathappa, Sarmistha Basak |
112 |
[GO] |
2021―Mar―30 |
Graphene versus coronavirus: A study of the graphene properties that can help to combat coronavirus |
T. Guerra, I. O. Assis, A. B. Guerra |
113 |
[GO] |
2021―Mar―16 |
Administration of exogenous surfactant and cytosolic phospholipase A2α inhibitors may help COVID-19 infected patients with chronic disease |
Mohammed Abdalla Hussein |
114 |
[GO] |
2021―Mar―10 |
Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges |
Habibur Rahman |
115 |
[GO] |
2021―Mar―10 |
New Perspectives for SARS-CoV-2 Rapid Detection |
Latifa Khattabi, Mustapha Mounir Bouhenna, Feriel Sellam |
116 |
[GO] |
2021―Mar―03 |
Effect of miRNAs, proinflammatory cytokines and ACE2 in COVID-19 pathophysiology |
Hari Om Singh, Kamini Jakhar, Vijay Nema, Asha Krishnaraj, Ranjana Choudhari |
117 |
[GO] |
2021―Mar―01 |
Therapeutically Important Natural Products and their Derivatives as a Target for Treatment of COVID-19 (SARSCoV2) |
Ashu Chaudhary |
118 |
[GO] |
2021―Mar―01 |
Economic Fluctuations- the Aftermath of COVID 19 Pandemic |
Saishiv Adithya, Koyeli Girigoswami |
119 |
[GO] |
2021―Feb―26 |
SARS-CoV-2: Molecular biology and therapeutic target. |
Vivek Pandey, Ankita Pathak, Mohammad Shahar Yar, Yuba Raj Pokharel |
120 |
[GO] |
2021―Feb―25 |
Antimicrobial Resistance: The Potent Enemy Lurking Behind COVID-19 |
Rohini Kanwar, Amit Kumar, Jyoti Rathee, Surinder K. Mehta |
121 |
[GO] |
2021―Feb―24 |
World’s proposed safeguard against COVID-19 - A brief review |
Sumanta Dey, Anindita Dey, Shreyans Chatterjee, Papiya Nandy, Ashesh Nandy |
122 |
[GO] |
2021―Feb―24 |
Controlling Coronavirus Infection: ‘Plan B’ based on non-vaccine/drug interventions |
Ram Kumar Dhaked |
123 |
[GO] |
2021―Feb―24 |
Clinical evidence and therapeutic treatments at the time of the coronaviruses responsible for SARS: a perspective and points of view with a focus on vascular endothelium. |
Gerardo Tricarico, Barbara Zavan, Valter Travagli |
124 |
[GO] |
2021―Feb―24 |
Current Trends and Future Strategies for the Global Impact of COVID-19 Pandemic |
Ashutosh Chauhan, Ankit Kumar, Sandeep Goyal, Sunil Kumar Joshi, Deepak Kumar Semwal |
125 |
[GO] |
2021―Feb―23 |
Virtual Screening of the Flavonoids Compounds with the SARS-CoV-2 3C-like Protease as the Lead Compounds for the COVID-19 |
Gabriella Patricia Adisurja, Arli Aditya Parkesit |
126 |
[GO] |
2021―Feb―23 |
Functionalized photocatalytic nanocoatings for inactivating COVID-19 virus residing on surfaces of public and healthcare facilities |
Manjunatha Channegowda |
127 |
[GO] |
2021―Feb―23 |
Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2 |
Vikas Pandey, Indu Lata Kanwar, Tanweer Haider, Vishal Gour, Monika Vishwakarma, Avijit Kumar Bakshi, Ravishankar Yadav, Vandana Soni |
128 |
[GO] |
2021―Feb―17 |
The synergic role of environmental contaminants on the immunological effects of viral diseases, such as COVID-19 |
Winfred Espejo, José E Celis, Paulina Bahamode |
129 |
[GO] |
2021―Feb―17 |
Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin-Like Main Protease (3CLpro) from Four Different Coronaviruses-: An in-silico Approach |
Prachi Singh, Mohamed Rafiq, Raghavendra Pralhada Rao |
130 |
[GO] |
2021―Feb―17 |
Immunological response of the respiratory tract in the SARS-CoV-2 infection |
Sanjiv Singh, Punita Aggarwal, Velayutham Ravichandiran |
131 |
[GO] |
2021―Feb―17 |
Prevention and management of SARS-CoV-2 infection among the health care workers |
Juhi Sharma, Divakar Sharma |
132 |
[GO] |
2021―Feb―12 |
Mesenchymal stem cells: A potent cell source for COVID-19 |
Mohammad Ramazii, Delnia Ebadi, Maryam Farzaneh, Farhoodeh Ghaedrahmati, Seyed Esmaeil Khoshnam |
133 |
[GO] |
2021―Feb―12 |
High Mutation Rate Leads to Fitness Loss for Coronavirus Quasispecies |
Khalid P, Arun A. Bhagwath, Rekha P.D, Sharif Hamed R. Almutiri, Ziyad Abdullah Al Zeyadi, Suman V. Budihal |
134 |
[GO] |
2021―Feb―11 |
An epidemiology, evolution, transmission, and therapeutics of COVID-19 Outbreak: an update on the status |
Karan Singh, Amit Kumar Mittal, Akash Gujral |
135 |
[GO] |
2021―Feb―09 |
An Integrated In-Silico Approach to Develop Epitope-Based Peptide Vaccine against SARS-CoV-2 |
Prekshi Garg, Neha Srivastava, Prachi Srivastava |
136 |
[GO] |
2021―Feb―09 |
COVID19 pandemic: An overview of its origin, current status and ongoing clinical trials |
Kartik Majila, Seema Lal, Mohammad Faiz Ahmad |
137 |
[GO] |
2021―Feb―04 |
Pathogenesis and immune status in COVID-19 pneumonia - A minireview |
George Laylson da Silva Oliveira, Nidia Aparecida Martines, Joelma da Costa Barbosa Oliveira |
138 |
[GO] |
2021―Feb―03 |
COVID-19 invades several important organs other than lungs: Organs crosstalk |
Manal A. Hamed |
139 |
[GO] |
2021―Feb―03 |
Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update |
Asim Azhar, Khaled Al-hosaini, Parvez Anwar Khan, Abdul M Oanz, Qamar Zia, Saeed Banawas, Jae-Jung Dong, Mohammad Amjad Kamal, Mohammad Owais |
140 |
[GO] |
2021―Jan―31 |
Adjuvant Therapies of COVID-19 - A Literature Review |
Naina Mohamed Pakkir Maideen |
141 |
[GO] |
2021―Jan―28 |
Diagnosis and possible use of Traditional Medicinal Plant to combat COVID-19 |
M. Beyau Konyak, Richa Naredi, Ekta Rana, Ramendra Pati Pandey |
142 |
[GO] |
2021―Jan―28 |
Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19. |
Jafrin Jobayer Sonju, Md Rafi Anwar, Md. Abul Kalam Azad, Umme Habiba Sultana, Kumar Kulldeep Niloy, Sajan Das |
143 |
[GO] |
2021―Jan―19 |
History and global status of the new coronavirus covid-2019 and aspects of previous infections of sars-cov and mers-cov: A systematic review |
Amanda Pinato Alves da Costa, Vinicius Lisboa da Rocha, Rogério Rodrigo Ramos, José Martins Pinto Neto, Wagner Rafael da Silva, Luis Lenin Vicente Pereira, Kelys Ramos, Tais Cristina Nascimento Marques, Idiberto José Zotarelli Filho, André Wilian Lozano |
144 |
[GO] |
2021―Jan―19 |
In silico insight into the inhibitory effects of active antidiabetic compounds from medicinal plants against SARS-CoV-2 replication and posttranslational modification |
Habibu Tijjani, Adamu Idris Matinja, Ahmed Olatunde, Maryam Haladu Zangoma, Abubakar Mohammed, Muhammad Akram, Akinwunmi Oluwaseun Adeoye, Hamza Lawal |
145 |
[GO] |
2021―Jan―18 |
A coadunation of biological and mathematical perspectives on the pandemic COVID-19: A Review |
Sahar Qazi, Kayenat Sheikh, Mo Faheem, Arshad Khan, Khalid Raza |
146 |
[GO] |
2021―Jan―13 |
COVID-19 and the challenges of chemotherapy: The failure case of hydroxychloroquine in the clinical treatment of SARS-CoV-2 infection |
Pollyanna Stephanie Gomes, Patrícia A. Machado, Andre M. O. Gomes, Andrea C. Oliveira, Jerson L. Silva, Herbert Leonel de Matos Guedes |
147 |
[GO] |
2021―Jan―13 |
COVID-19 (SARS-CoV2): Consequences, Possible Therapeutics and Future Directions for Prevention & Treatment |
Ashu Chaudhary |
148 |
[GO] |
2021―Jan―13 |
Immunity modulators, Repurposed drugs and Candidate Vaccines for COVID-19: A Review |
Rashmy Nair, Ravindra Singh Rao, Placheril Joseph John, Poonam Khandelwal |
149 |
[GO] |
2021―Jan―12 |
A Mini Review on COVID-19 Therapeutics: Current Status and Future Directions |
Niranjan Kaushik, Vikram Sharma, Vikas Sharma |
150 |
[GO] |
2021―Jan―11 |
Cellular senescence and COVID-19 |
Farhan Rahman Chowdhury, Tofazzal Islam |
151 |
[GO] |
2021―Jan―11 |
Hydroxychloroquine Sulfate (Plaquenil): A possible candidate for Pandemic SARS-CoV-2 or (COVID-19) ? |
Subhash Chandra, Sarla Saklani, Hassan Y. Aboul-Enein |
152 |
[GO] |
2021―Jan―08 |
Stroke and COVID-19 pandemic: the dilemma |
Sherif Mohamed, Seham Abd El-Mohsen, Osama Abo El-Hassan, Azza AbdelHaffez, Nashwa Abd El-Aziz |
153 |
[GO] |
2021―Jan―06 |
Safe Use of Sodium Dodecyl Sulfate (SDS) to Deactivate SARS-CoV-2: An Evidence-Based Systematic Review |
Ashok Kumar, Waseem Ahmad Ansari, Tanveer Ahamad, Mohammad Saquib, Mohammad Faheem Khan |
154 |
[GO] |
2021―Jan―04 |
Is COVID-19 a systemic disease? |
Sherif Mohamed, Khaled Saad, Ghada Elgohary, Azza AbdElHaffez, Nashwa Abd El-Aziz |
155 |
[GO] |
2021―Jan―04 |
Remdesivir (GS-5734) for COVID-19 Treatment: Past and Recent Updates |
Santhosh Arul, Haripriya Dayalan |
156 |
[GO] |
2021―Jan―03 |
Psychological Impact of Coronavirus (COVID-19) Disease on Cancer Patients |
Gaurav Dhiman |
157 |
[GO] |
2020―Dec―31 |
Repositioning of Drugs as a promising strategy to fight COVID-19 |
Vivek Yadav, Jurnal Reang, Vinita Sharma, Jaseela Majeed, Swaminathan Jambulingam, Ramesh Goyal, Rajiv Kumar Tonk |
158 |
[GO] |
2020―Dec―31 |
A critical appraisal of the risk of bias in systematic reviews and metaanalyses pertaining to COVID-19 |
Amit Dang, Sheshank Madiraju, Jagan Mohan Venkateswara Rao P, Navya Sri Gurram, Sandeep Digijarala, Sumit Dang, Vallish BN |
159 |
[GO] |
2020―Dec―31 |
2019 Novel Coronavirus: A review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development |
Megala Jayaraman, Sabari Krishna B. B., Parijat Dutta, Jayesh Telang, Sreshta Adhikari, Arpan Neeraj Pardeshi |
160 |
[GO] |
2020―Dec―31 |
Pleiotropic effects of Nitric Oxide on SARS-CoV-2 Infections |
Barbara Terroni, Juliana Romano Lopes, Chung Man Chin, Jean Leandro Dos Santos |
161 |
[GO] |
2020―Dec―29 |
Management of COVID-19 very elderly patients in Nursing Homes and Long-Term Care Facilities: Description of a new model and experience in a medicalized Nursing Home |
Ignacio Novo-Veleiro, Martín Vidal-Vazquez, Néstor Vázquez-Agra, Eduardo-David Otero Rodríguez, Paula Andújar-Plata, Belen Calvo-Martínez, Irene Espasandín-Duarte, Francisco Javier Martínez-Bahamonde, Beatriz Pais-Iglesias, Eloína Núñez-Masid, Antonio Pose-Reino |
162 |
[GO] |
2020―Dec―24 |
A Perspective On The Impact of COVID-19 Pandemic in Basic Science Research and its Future implications |
Yam Nath Paudel, Efthalia Angelopoulou, Bhupendra Raj Giri, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh |
163 |
[GO] |
2020―Dec―24 |
In-silico Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors against Main Protease of SARS-CoV-2 |
Ravi S Patel, Akash G Vanzara, Nimisha R Patel, Ajit M Vasava, Sachin M Patil, Kishore S Rajput |
164 |
[GO] |
2020―Dec―23 |
Current Drug Trends for the Treatment of SARS-CoV-2 |
Márcio Robert Mattos da Silva, Melanie Tavares, Ralph Santos-Oliveira, Eduardo RicciJúnior |
165 |
[GO] |
2020―Dec―23 |
Boosting innate immunity during SARS-CoV-2 clearance |
Abhishesh Kumar Mehata, Deepa Dehari, Anuj Kumar Mehta, Alim Miya |
166 |
[GO] |
2020―Dec―21 |
Impact of Metaheuristic Techniques in Pandemic of COVID-19 |
Vijay Kumar, Dilbag Singh, Manjit Kaur |
167 |
[GO] |
2020―Dec―21 |
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov-2 Infection and COVID-19 |
Carolina Restini, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim, Courtney Merlo |
168 |
[GO] |
2020―Dec―21 |
Molecular insights into Resveratrol and its analogs as SARS-CoV-2 (COVID-19) protease inhibitors |
Vaishali M. Patil, Rohan R. Narkhede, Neeraj Masand, Rameshwar S. Cheke, Krishnan Balasubramanian |
169 |
[GO] |
2020―Dec―21 |
Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope |
Kuldeep Singh, Dilpreet Singh, Karan Razdan |
170 |
[GO] |
2020―Dec―15 |
Coronavirus Pandemic: Role of Bats And Zoonotic Transmission in Humans |
Baljinder Singh, Jasleen Kaur, Sumeet Gupta |
171 |
[GO] |
2020―Dec―15 |
Review on Diagnostic Methods for SARS-CoV-2 |
Chandrashekhar Chauriya, Mahesh Sahu, Anuj Kumar Singh, Amita Verma |
172 |
[GO] |
2020―Dec―10 |
COVID-19: how nuclear medicine can provide a differential diagnosis in very dubious case |
Maria Silvia De Feo, Viviana Frantellizzi, Giuseppe De Vincentis |
173 |
[GO] |
2020―Dec―10 |
The Genomes of SARS-CoV-2 and Related Coronaviruses: Are Accessory Proteins Key for Pathogenesis? |
Saikat Samanta, Rudra Prasad Saha |
174 |
[GO] |
2020―Dec―10 |
Nigella Sativa: An immunity booster as pandemic treatment solution against SARS-CoV-2 |
Afzal Hussain, Ashfaq Hussain, Chandan Kumar Verma |
175 |
[GO] |
2020―Dec―10 |
The role of nanoparticles as nanocarriers for the controlled release of some potential existing antiviral drugs for SARS-CoV-2 management: A Review |
Onome Ejeromedoghene, Joshua I. Orege, Justina U. Onwuka, Philip A. Adebule, Teddy Ehianeta, Bright O. Okonkwo, Richard O. Akinyeye |
176 |
[GO] |
2020―Dec―10 |
SARS-CoV-2: Origin, pathogenesis and Therapeutic Interventions |
Ipsita G Kundu, NNV Radharani, Amit S Yadav, Srinivas Patnaik, Gopal C Kundu |
177 |
[GO] |
2020―Dec―05 |
Recent developments and opportunities in fighting COVID-19 |
Vikram Rao, Subrat Kumar Bhattamisra |
178 |
[GO] |
2020―Dec―05 |
Outbreak of coronavirus disease 2019 (COVID-19) and its manifestation |
Bikash Debnath, Waikhom Somraj Singh, Kuntal Manna |
179 |
[GO] |
2020―Dec―05 |
Major drugs used in COVID-19 treatment: molecular mechanisms, validation and current progress in trials |
Md. Asaduzzaman Khan, Shad Bin Islam, Mejbah Uddin Rakib, Didarul Alam, Md. Munnaf Hossen, Mousumi Tania, Asaduzzaman Asad |
180 |
[GO] |
2020―Dec―05 |
Safety and Efficacy of Convalescent Plasma Therapy for the Management of COVID-19: A Systematic Review |
Sitaram Khadka, Muhammad Saleem, Dhan Bahadur Shrestha, Pravash Budhathoki |
181 |
[GO] |
2020―Dec―05 |
Covid-19: An update on the clinical features, diagnosis, and treatment strategies. |
Manan Abdulrahman Alhkbany |
182 |
[GO] |
2020―Dec―05 |
Therapeutic options for the treatment of 2019-novel coronavirus in India: A systematic review |
Pratyay Kumar Pahari, Sonal Vyas, Shahbaz Aman, Uday Singh, Kusheswar Prasad Singh, Rohit Tiwari, Meenakshi Dhanawat |
183 |
[GO] |
2020―Dec―04 |
Chemi-Informatic approach to investigate putative pharmacoactive agents of plant origin to eradicate COVID-19 |
Amit Joshi, Vandna Sharma, Joginder Singh, Vikas Kaushik |
184 |
[GO] |
2020―Dec―04 |
In silico identification of potential inhibitors of SARS-CoV-2 papain-like protease from natural sources: A natural weapon to fight COVID-19 |
Bimal Debnath, Pradip Debnath, Rajat Ghosh, Sudhan Debnath |
185 |
[GO] |
2020―Dec―04 |
Coronavirus (Covid-19) and employee health |
Ali Mehrabi Tavana, Mohamadkarim Bahadori |
186 |
[GO] |
2020―Nov―24 |
COVID-19: A daily dose of yoga to cope with anxiety |
Surabhi Gautam, Rima Dada |
187 |
[GO] |
2020―Nov―24 |
Is there any role for IL-6 inhibition in COVID-19? |
Rebecca Cannon, Satyajit Das |
188 |
[GO] |
2020―Nov―24 |
The emergence of novel coronavirus disease, global treatment update and its containment strategies in overpopulated countries: A Review |
Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, MD Sarfraz, Nawshad Muhammad, Syed A. A. Rizvi |
189 |
[GO] |
2020―Nov―20 |
COVID-19 Effect: Time to Change the Way of Research |
Vikas Sharma |
190 |
[GO] |
2020―Nov―20 |
Structure, transmission, diagnostic symptoms, host and entry mechanism of covid-19: A review |
Prashant Swapnil, Mukesh Meena, Tansukh Barupal, Yashwant Sompura, Deepa Hada |
191 |
[GO] |
2020―Nov―20 |
A Journey of Coronaviruses from Sporadic Outbreaks to COVID -19 Pandemic |
Suresh Kumar, Perumal Nagarajan |
192 |
[GO] |
2020―Nov―19 |
Clinical spectrum, geographical variability of COVID-19 and its implications |
Md. Hasanul Banna Siam, Abdullah Al Mosabbir, Nahida Hannan Nishat, Ahsan Ahmed, Mohammad Sorowar Hossain |
193 |
[GO] |
2020―Nov―19 |
Psychological and Mental Health Issues During SARS-CoV-2 Global Pandemic: A Critical Analysis |
Tahmeena Khan, Iqbal Azad, Alfred J. Lawrence |
194 |
[GO] |
2020―Nov―17 |
Impact of Novel Coronavirus (COVID-19) on Pregnant Women: A Review |
Saima Habeeb, Manju Chugani |
195 |
[GO] |
2020―Nov―17 |
Current advances in novel SARS-CoV-2 disease (COVID-19) treatment and intervention strategies |
Mohammad Khalid Parvez, Kartika Padhan |
196 |
[GO] |
2020―Nov―17 |
Anticipating on a post covid-19 world and the pivotal role of science and technology |
Saeed Khan, Tusha Sharma, Basu Dev Banerjee, Scotty Branch, Shea Harrelson |
197 |
[GO] |
2020―Nov―13 |
COVID-19 Pandemic: Current Scenario, Challenges and Future Perspectives |
Ovais Ahmad Zargar, Rabia Hamid, Rohina Bashir, Mohammad Afzal Zargar |
198 |
[GO] |
2020―Nov―13 |
Structure based drug design approach to identify potential SARS-CoV-2 polymerase inhibitors. |
Preeya Negi, Surya Prakash, Vaishali M. Patil |
199 |
[GO] |
2020―Nov―11 |
Novel Coronavirus Disease 2019 (COVID-19) Current Update; Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines |
Sunil L. Harer, Priyanka A. Sonar |
200 |
[GO] |
2020―Nov―05 |
Antiviral potential of coconut (Cocos nucifera L.) oil and COVID-19 |
Ramesh S.V., Pandiselvam R, Hebbar K. B., Manikantan M.R., Shameena Beegum P.P., Shelly Praveen, Sruthi N. U |
201 |
[GO] |
2020―Oct―27 |
A Mini-review on Cardiovascular and Hematological Complications of COVID-19 |
Moein Masjedi, Pegah Jafari |
202 |
[GO] |
2020―Oct―27 |
The Current Outbreak of COVID-19 with reference to India |
Harshita Gupta |
203 |
[GO] |
2020―Oct―27 |
Review of the Times When One-Third of the Mankind is Under Lockdown due to Coronavirus |
Pramod Gware, Deepanshu Gulati |
204 |
[GO] |
2020―Oct―27 |
Vaccine development against SARS-CoV-2: from virology to vaccine clinical trials |
Kimia Kardani, Azam Bolhassani |
205 |
[GO] |
2020―Oct―27 |
Manuscript title: “COVID-19 pandemic: care for Indian cancer patients” |
Sandeep Kumar |
206 |
[GO] |
2020―Oct―23 |
Nanomaterial: A Sustainable Way to Fight against COVID-19 |
Atish K. Maldhure |
207 |
[GO] |
2020―Oct―18 |
Combination of Hydroxychloroquine, Melatonin and Mercaptopurine as possible intervention for prophylaxis and treatment of Novel COVID-19 infection |
Gyan Vardhan, Vikas Kumar, Megha Agrawal, Puneet Dhamija |
208 |
[GO] |
2020―Oct―15 |
A Study about the impact of weather, life expectancy and tourism on the transmission of COVID-19 |
Pardeep Bishnoi, Prabhat Kumar, Abhijeet Singh, Mukesh Sahu, Vikrant Bansal |
209 |
[GO] |
2020―Oct―15 |
Synthetic Lung Surfactant Treatment for Covid-19 Pneumonia |
Frans J. Walther, Alan J. Waring |
210 |
[GO] |
2020―Oct―15 |
Emergence of a new zoonotic covid-19 that creates a pandemic: Update on current pharmacotherapeutics and future prospective of plasma therapy |
Farazul Hoda, Rishabh Verma, Saurabh Rastogi, Asif Iqubal, Syed Ehtaishamul Haque, Mohd. Akhtar, Abul Kalam Najmi |
211 |
[GO] |
2020―Oct―15 |
Possible benefits of reformulating antiviral drugs with nanoemulsion system in the treatment of novel coronavirus infection |
Manish Kumar, Chandra Prakash Jain |
212 |
[GO] |
2020―Oct―15 |
In-silico Structure-Based Drug Discovery of Candidate Drugs against Novel Protein Receptor Complex Nsp10-Nsp16 of SARS-CoV-2 using Drug Repurposing Approach |
Abhishek Sengupta, Pooja Vijayaraghavan, Priyansh Srivastava, Lovely Gupta, Chaitanya Chandwani, Priyanka Narad |
213 |
[GO] |
2020―Oct―07 |
Impact of Online Teaching on Students’ Education and Health in India during Pandemic of COVID-19 |
Avadhesh Kumar Yadav |
214 |
[GO] |
2020―Oct―07 |
Impact of BCG Vaccine to Fight Against the Pandemic of Corona (COVID-19): A Review |
Rana Mazumder, Subhabrota Majumdar |
215 |
[GO] |
2020―Oct―07 |
Coronavirus disease 2019 (COVID-19): Current situation and therapeutic options |
Veer Singh, Vishal Mishra |
216 |
[GO] |
2020―Oct―07 |
COVID-19 Epigenetics and Implications for Public Health |
Verda Tunalıgil, Gülsen Meral, Ahmet Katı, Dhrubajyoti Chattopadhyay, Amit Kumar Mandal |
217 |
[GO] |
2020―Oct―07 |
Nutritional intervention for the treatment and prevention against novel coronavirus-19 |
Abdul Wahab, Fahad Hassan Shah |
218 |
[GO] |
2020―Sep―29 |
Dual modulators of selected plant secondary metabolites targeting COVID-19 Main protease and Interleukin-2: An in-silico approach based novel hypothesis |
Thangavelu Prabha, Vijay K. Kapoor, Palanisamy Selvamani, Subbiah Latha, Thangavel Sivakumar, Selvaraj Jubie |
219 |
[GO] |
2020―Sep―29 |
Hydroxychloroquine Induced DRESS (Drug Rash with Eosinophilia and Systemic Symptoms Syndrome) Mimicking SARS-COV-2 Illness: A Case Report with Review |
Maitri M. Patel, Dhruvkumar M. Patel, Mukundkumar V. Patel, Jayanti K. Gurumukhani, Suyog Y. Patel, Harsh D. Patel |
220 |
[GO] |
2020―Sep―26 |
COVID-19 infection: A review of summarized Clinical trials study for the treatment |
Afzal Hussain, Ashfaq Hussain, Chandan Kumar Verma |
221 |
[GO] |
2020―Sep―22 |
Novel Corona-Virus Disease 2019 (COVID-19): A Perilous LifeThreatening Epidemic |
Surya Goel, Ram Dayal |
222 |
[GO] |
2020―Sep―22 |
Discovery of Potential Inhibitors of SARS-CoV-2 (COVID-19) Main Protease (Mpro) from Nigella Sativa (Black Seed) by Molecular Docking Study |
S. L. Khan, F. A. Siddiqui, S. P. Jain, G. M. Sonwane |
223 |
[GO] |
2020―Sep―22 |
COVID-19: Mitigation is good! Prophylactics are better! Treatment is the best! |
Prabagaran Narayanasamy |
224 |
[GO] |
2020―Sep―21 |
Understanding the role of HDL during COVID-19 infection |
Iti Garg, Swati Srivastava, Bhuvnesh Kumar |
225 |
[GO] |
2020―Sep―21 |
COVID-19: Insights into Structure-Function Relationship, Drug Targets and Drug Design Strategies for novel-Coronavirus 2019 |
Snigdha Bhardwaj, Shaminder Singh, Sonam Bhatia |
226 |
[GO] |
2020―Sep―18 |
Coronavirus: history, genome structure and pathogenesis |
Poonam B, Prabhjot Kaur Gill |
227 |
[GO] |
2020―Sep―18 |
A Review on Catastrophic Evolution of SARS-CoV to SARS-CoV2-A Global Pandemic |
Sushmita Krishnan, Darshini Subramanian, Sri Sakthi Priyadarshini Rajamani |
228 |
[GO] |
2020―Sep―16 |
Insights into the Positive Role of a Higher Education Institution in the Prevention of Misinformation During Pandemics: The Health Committee Model During COVID-19 |
Dalal Hammoudi Halat, Marwan Akel, Fatima Hajj, Hassan HajjHussein, Rawad Kansoun, Ehsan Sharif-Askari, Lama Siblani, Ahmad Faraj |
229 |
[GO] |
2020―Sep―16 |
Yoga may prevent cytokine storm in COVID-19 |
Surabhi Gautam, Rima Dada |
230 |
[GO] |
2020―Sep―16 |
Utilizing Zebra fish animal model as a helping hand for COVID-19 infection |
Yashbir Singh, Heenaben Patel, Amit Chaudhary, Deepa S |
231 |
[GO] |
2020―Sep―16 |
Dental care during the COVID-19 pandemic. |
Caio Vinicius G. Roman-Torres, Marcelo de Melo Quintela |
232 |
[GO] |
2020―Sep―16 |
Prediction of infection and death ratio of CoVID-19 virus in Turkey by using artificial neural network (ANN) |
Andaç Batur Çolak |
233 |
[GO] |
2020―Sep―16 |
Covid-19: An Insight over the Third Respiratory Global Emergency of the Century |
Sonali Batra, Sumit Sharma, Payal Verma, Nikhil Arora |
234 |
[GO] |
2020―Sep―16 |
Can Cannabinoids Suppress the Cytokines Cascade in Patients with Coronavirus Disease COVID-19? A mini-review |
Hanane Zaki, Mohammed Bouachrine |
235 |
[GO] |
2020―Sep―15 |
Vitamin D3 Deficiency and COVID-19. |
Olen R. Brown, Martin R. Hullender |
236 |
[GO] |
2020―Sep―12 |
SARS-CoV-2 and its Predicted Potential Natural Inhibitors: A Review and Perspective |
Priyanka Samji, Manoj Kumar Rajendran, Vidya P Warrier |
237 |
[GO] |
2020―Sep―09 |
Dealing with COVID-19: lessons learned from the Italian experience |
Silvana Mirella Aliberti, Francesco De Caro, Giovanni Boccia, Rosario Caruso, Mario Capunzo |
238 |
[GO] |
2020―Sep―05 |
A Brief outlook on possible available solutions, therapies and suggestions for COVID-19 |
Rashmi Saxena Pal, Yogendra Pal, Pranay Wal, Ankita Wal, Nikita Saraswat |
239 |
[GO] |
2020―Sep―05 |
COVID-19: A comparative study of SARS, MERS and COVID-19 |
Chandra Mohan, Vinod Kumar |
240 |
[GO] |
2020―Sep―05 |
Impacts and consequences of COVID-19 epidemic on global economy |
Pallavi Nayak, Vijay Mishra, Manvendra Singh, Murtaza M. Tambuwala |
241 |
[GO] |
2020―Sep―05 |
COVID-19 Pandemic: Age and Temperature Related Effects |
Gursharan Kaur, Amandeep Singh, Raj Kumar Narang, Gurmeet Singh |
242 |
[GO] |
2020―Sep―05 |
Non-Pharmaceutical Interventions are measures to control coronavirus disease-2019 (COVID-19) transmission in India |
Ponnuswamy Vijayaraghavan, Srikrishnan Rajendran Sriramkumar |
243 |
[GO] |
2020―Sep―05 |
The outbreak of Novel Coronavirus a New Type of Threat in 2020: Genesis, Detection, Treatment, and Management |
Dinesh Mohan S, Santhosha D, Gupta VRM, Mrunalini S |
244 |
[GO] |
2020―Sep―02 |
Novel Coronavirus in India Outbreaks around World: A Statistical Analysis of Odisha, India & World |
Debabrata Singh, Suman Sekhar Sarangi, Milu Acharya, Surjeet Sahoo, Shakti Ketan Prusty, Sudhanshu Rout |
245 |
[GO] |
2020―Aug―27 |
Virtual screening of potential therapeutic inhibitors against spike, helicase and polymerase of SARS-CoV-2 (COVID-19) |
Ayesha Tazeen, Farah Deeba, Aftab Alam, Rafat Ali, Romana Ishrat, Anwar Ahmed, Sher Ali, Shama Parveen |
246 |
[GO] |
2020―Aug―27 |
A Mini Review: Origin, Treatments, Preventions, Real Facts and Viability of the Recent Pandemic of Novel Coronavirus-2019 |
Prashant Kantrao Vibhute, Satish Babulal Jadhav, Satish Ashruba Dake, Bhaskar Sadashiv Dawane |
247 |
[GO] |
2020―Aug―26 |
The COVID-19 and Munchausen Syndrome |
Yadollah Abolfathi Momtaz |
248 |
[GO] |
2020―Aug―22 |
Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread |
Keith Lau |
249 |
[GO] |
2020―Aug―19 |
Dengue, Influenza and COVID-19 in Brazil: The "Perfect Storm" |
Rosineide Marques Ribas, Paola Amaral de Campos, Cristiane Silveira de Brito, Paulo Pinto Gontijo Filho |
250 |
[GO] |
2020―Aug―19 |
An Overview on Covid-19: Clinical Features, Treatment and Prevention |
Shahid Ud Din Wani, Surya Prakash Gautam, Zulfkar Latief Qadrie |
251 |
[GO] |
2020―Aug―16 |
COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies |
Kirtikumar C. Badgujar, Dipak V. Patil, Dipak V. Dhangar, Vikrant P. Patil, Ashish B. Badgujar |
252 |
[GO] |
2020―Aug―16 |
COVID-19: The Unprecedented Malady-A Holistic Review |
Viney Chawla, Pooja A Chawla |
253 |
[GO] |
2020―Aug―03 |
Homology Modeling of Coronavirus Structural Proteins and Molecular Docking of Potential Drug Candidates for the Treatment of COVID-19 |
Ahmed Adebayo Ishola, Nnaemeka Tobechukwu Asogwa |
254 |
[GO] |
2020―Aug―02 |
Coordinated Roadmap to Grip Pandemic Covid-19 |
Rohini S. Kharwade, Sachin M. More |
255 |
[GO] |
2020―Jul―30 |
Favipiravir in the Spotlight: In search of treatment against COVID-19 |
Marcus Vinícius Nora de Souza, Victor Facchinetti |
256 |
[GO] |
2020―Jul―30 |
Off label medication to combat COVID-19: Review Results to Date. |
Amita Verma, Anuj Kumar Singh, Aman K. Das, Netra P. Neupane |
257 |
[GO] |
2020―Jul―30 |
Self-Protection of Medical Workers in Traditional Hospitals and Clinics against SARS-CoV-2 Infection |
Suneel Prajapati, Pankaj Gupta, Digvijay Verma, Shilpi Singh, Ashish Tripathi, Mahima Sharma, Arun Kumar, G.V Narasimha Kumar |
258 |
[GO] |
2020―Jul―22 |
A Note on Estimating the Case Fatality Ratio for Novel Corona Virus Disease (Covid-19) |
Prafulla Kumar Swain |
259 |
[GO] |
2020―Jul―22 |
SARS-CoV-2 Therapy: Old drugs as new interventions |
Puneet K. Samaiya, Mahendra Kumar |
260 |
[GO] |
2020―Jul―14 |
Study of the Relationships Between COVID-19, Associated Diseases, and Vitamins |
Alice Barros Câmara, Igor Augusto Brandão |
261 |
[GO] |
2020―Jul―14 |
Amantadine Can be Used as a Drug for SARS-Cov-2 Treatment? |
Zeynep Gunes Ozunal, Sevki Sahin |
262 |
[GO] |
2020―Jul―14 |
Symptoms, transmission, prevention and treatment of pandemic corona virus: A review |
Tinsae Kebede, Dharmendra Kumar, Pramod Kumar Sharma |
263 |
[GO] |
2020―Jul―10 |
Pathogenesis, Clinical Manifestation, Diagnosis, Pathological Findings, Treatment Options, Preventive Measures and Risk Factors Of Covid-19 |
Mohammad Asif, Anshuman Patel, May Bin-Jumah, Sadaf Jamal Gilani, Iqra Rahat, Mohamad Taleuzzaman, Neha Gandhi, Syed Sarim Imam, Chandra Kala |
264 |
[GO] |
2020―Jul―10 |
Covid-19: Doomsday, Shoved Away? |
Zahid Dar, Lucky Chauhan, Monika Chauhan, Navpreet Kaur, Tanzeer Kaur, Neelima Dhingra |
265 |
[GO] |
2020―Jul―02 |
Revealing potential binding affinity of FDA approved therapeutics targeting Main protease (3CLpro) in impairing novel coronavirus (SARS-CoV-2) replication that causes COVID-19 |
D. Sivaraman, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela, V. Venugopal |
266 |
[GO] |
2020―Jul―02 |
The comprehensive appraisal of COVID-19, it’s clinical panorama from virology till management and beyond. |
Iftikhar Haider Naqvi, Saiyeda Nayema Zehra Rizvi |
267 |
[GO] |
2020―Jul―02 |
Potential Drug Options for Treatment Process of COVID-19: A Review |
Tinsae Kebede, Dharmendra Kumar, Pramod Kumar Sharma |
268 |
[GO] |
2020―Jul―02 |
Impact and Inescapable Effects of Coronavirus: History to Modern Pandemic Episode |
Suman K Ray, Yamini Meshram, Sukhes Mukherjee |
269 |
[GO] |
2020―Jun―29 |
A note on the potential BCG vaccination - COVID-19 molecular link |
Alex Y. Strongin, Alex Sloutsky, Piotr Cieplak |
270 |
[GO] |
2020―Jun―26 |
Activity of some novel Chalcone substituted 9-anilinoacridines against Coronavirus (COVID19): A computational approach |
Rajagopal Kalirajan |
271 |
[GO] |
2020―Jun―26 |
Potential immunotherapy against SARS-CoV-2: Strategy and status |
Abid H. Banday, Shameem A. Shah, Sheikh J. Ajaz |
272 |
[GO] |
2020―Jun―24 |
Critical insight into the attributes of emerging novel Coronavirus (COVID-19) in India and across the world |
Gaurav M Doshi, Hemen S Ved, Ami P Thakkar |
273 |
[GO] |
2020―Jun―24 |
COVID-19: Opinion in Prevention and dietary based management hypothesis |
Ashraf Talaat Youssef |
274 |
[GO] |
2020―Jun―22 |
The COVID-19 and Ageism in Social Media |
Yadollah Abolfathi Momtaz |
275 |
[GO] |
2020―Jun―22 |
Unfortunate Welcome of Evil nCovid-19 in 2020: From Despair to Hope |
Ravi Varala, Haribabu Bollikolla |
276 |
[GO] |
2020―Jun―17 |
Coronavirus (COVID-19) Effects on Psychological Health of Indian Poultry Farmers |
Gaurav Dhiman |
277 |
[GO] |
2020―Jun―17 |
Update on the SARS-CoV-2 (COVID-19) Outbreak: A Global Pandemic Challenge |
Abhishek Kumar Soni |
278 |
[GO] |
2020―Jun―17 |
COVID-19: could irisin become the handyman myokine of the 21th century? |
Alessia Catalano |
279 |
[GO] |
2020―Jun―17 |
COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario |
Tansukh Barupal, Praveen Kumar Tak, Mukesh Meena |
280 |
[GO] |
2020―Jun―17 |
Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools. |
Rohit Bhatia, Raj Kumar Narang, Ravindra Kumar Rawal |
281 |
[GO] |
2020―Jun―17 |
Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach |
Sibi Raj, Vaishali Chandel, Brijesh Rathi, Dhruv Kumar |
282 |
[GO] |
2020―Jun―15 |
A Preliminary Review on Novel Coronavirus Disease: COVID-19 |
Miranji Katta, Satish Rapaka, Ramkumar Adireddi, Jagadeeshwara Rao Emandi |
283 |
[GO] |
2020―Jun―07 |
The Relationship between Opium Use and Coronavirus Infection, A Brief Research Report from Iran |
Hadi Khoshab, Mohammadreza Rajabalipour |